Baxter International | BAX - PE Price to Earnings


Baxter International reported 86 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Abbott 24.94 5.78 Mar/2026
AngioDynamics 8.82 1.6 Mar/2024
Artivion 212.38 16.51 Dec/2025
AtriCure 34.15 2.7 Jun/2022
Avanos Medical 18.02 108.8 Mar/2026
Baxter International 86 68.9 Dec/2025
Becton, Dickinson and Co. 17.68 114.67 Dec/2025
Boston Scientific 32.35 5.17 Mar/2026
Cooper Companies 23.27 16.99 Mar/2026
Dexcom 24.73 7.45 Mar/2026
Edwards Lifesciences 26.86 4.76 Mar/2026
Fresenius 15.18 0.63 Dec/2025
Globus Medical 35.3 10.24 Mar/2026
Halozyme Therapeutics 11.35 11.8 Mar/2026
ICU Medical 158.3 38.83 Dec/2025
Inogen 69.33 30.67 Sep/2021
Insulet 38.83 16.24 Mar/2026
Integra LifeSciences 5.07 1.52 Mar/2026
Intuitive Surgical 55.82 15.79 Mar/2026
J&J 24.53 0.91 Mar/2026
Laboratory Of America 25.51 4.65 Mar/2026
Medtronic 19.66 3.1 Mar/2026
Merit Medical Systems 45.2 6.08 Dec/2025
Quest Diagnostics 22.4 2.63 Mar/2026
Smith & Nephew 17.63 4.2 Dec/2025
Stryker 30.44 1.69 Mar/2026
Tandem Diabetes Care 681.05 189.32 Mar/2022
Teleflex 49.25 21.46 Mar/2026
Terumo 22.88 2.76 Mar/2026
Zimmer Biomet Holdings 25.47 7.56 Mar/2026